{"name":"MediPrint Ophthalmics, Inc.","slug":"mediprint-ophthalmics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbk91SWw5cmEtMzhiRXhJNmRsVnpBaWhfcXg0T0h5Szh4Tm1zSGk0V1h1emxUcVRmaVgyczdpM1ZXXzJFYVBvWXRuNGpXckd1NjJzWmU0ZVFNMmpJSFl6dTFDR0I3Zzk0VURWZmo0bGl1Zl9hbHhOY1k3elhSNXlXM09HeDlMNk5mSFlZajQxSDctOGl5c0ZtYm9fbnZ6aEU?oc=5","date":"2026-04-03","type":"earnings","source":"openPR.com","summary":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034 - openPR.com","headline":"Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNeFVfZ1F2LWFobnBLNENTMHJUZ2tTUkMtT2JTSXNlOG04NHdlbDN0c2dWcldFaWYzakxuNjRnc0Q1TWJ1VndOSWVhblpUazd1bGhXbGhxUWhRNi1HZVpHalBJbVc0QVRhMXVjSlMtdHJHUEdmME1OcTktb0tDUEY5OXVWZU1sQ1NxYURrUWdEYzZucjVDNmJjZXZhOGRjMUxVMEc4RHFsMGF1SEl4NVMwdTk3NEt1SW1kWkpEb2UwbHRWbVpNbHRiNmhnWlBXVkJxeWR1SWZ4a0k1UlZ5dmpSWllSU29tSU92NXc?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Ocular Hypertension Pipeline Demonstrates Strong Momentum with 50+ Companies Advancing 75+ Therapies | DelveInsight - Barchart.com","headline":"Ocular Hypertension Pipeline Demonstrates Strong Momentum with 50+ Companies Advancing 75+ Therapies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxOTlQzRkpQQlZDZXVlTFU3RzJWVV9HN3RhdWxyQ1gxdGJDaHFvZWpFQy1tOWRDbXhESDk2RkVWajdQZ2NhSTFncGlxTF9WTEVXMTdYZlhWdmd6NVI3b1FTbGdCZjNGTXBrVWp3S19GUF9DZlh0OFF3RXI0cU1XMFZhVXFzZjJZVkNpUU95bm9Jc0Y3Sm9yMkFoQ1dTTzNPb29PY0MwZ2VWaXJNR3d0WHgtY1BXV0FFWlMzZFRwdGl6VmR5U2xGMUNSLTRLdm9UQ2p6dVlvYU1BemYySTVLTE5va3ZFdmxvb0thRXNUNzlCVWJld0VuUDZn?oc=5","date":"2025-09-09","type":"pipeline","source":"PR Newswire","summary":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight - PR Newswire","headline":"Open-Angle Glaucoma Market Outlook Brightens as Emerging Therapies Reshape Treatment Paradigms | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNeTE2Q09aRVAxeVk4c3RXdlpDaEZVV3gyYTdDLURRekhnZ203ajJUYWhxWWthSEJGS3FJdDdFckJzRTRWeVp0NWQtUDlWcVhXSnE5ZTFGOFRrQjA3Yi1qc2VtaTZiLXRDcXAwT1liaHB6SEoxZWtKZkszMzJPMDJWOVNfRzl4b1BxQ1ZfTndfblNlcXdNNnNsVkVrejAwZXFVdFZmZmV3MnRqTXk1OE1XQ182ek84c28yX1BMYW5NNXJZQmU2eUNOZURkcDVfeTZYUDUwejRFZ0Q5alFyZEJyNXhPa0pQbS1O?oc=5","date":"2025-03-05","type":"pipeline","source":"Business Wire","summary":"MediPrint Ophthalmics Expands Clinical Program to Address Contact Lens Dropout Due to Discomfort - Business Wire","headline":"MediPrint Ophthalmics Expands Clinical Program to Address Contact Lens Dropout Due to Discomfort","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxONzJwRzBpN1dGQ1h1QkRLdEFDQnRrcTJhMUkwSTJRdk9uZWJkVUZOd2VNel8tTWlJYzZkSzdJSG9nRXRuZFpkVFpEV1RKMDBvTWlkNnRaN3BzVUU5SWdZZDVwc1djWWhEaVhPRjlxWS15RDRJbm9hS29hQllqQktObGtUTDZ6OHlRQ2F4ZGlNQzFRUlpNakd2MkdiU244N3hLX3lka3FHS3VoTlVtbzJ2LXk2UHJ0ckZ5VjdGUi1MSUFRaU5YX2kxb2tOUnJoUFItM256NTFaaHhRSlpFRjdNVWE1eEZmY3RzdW5LZmZGcmI4dEVaNFlWcmZFQ3RXRVhfaGctMVhYTm9pdVMyaUx4ZC1feDh1SGk2czRLRUJzaDQydWVlWUdQUFR6bzJ5c09PaUtCWFNoQQ?oc=5","date":"2025-02-26","type":"pipeline","source":"GlobeNewswire","summary":"DURYSTA’s Market Potential Across the 7MM is Set to Soar - GlobeNewswire","headline":"DURYSTA’s Market Potential Across the 7MM is Set to Soar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPTjRMZHc4NUhfVGZUR0RYR2RwX2tLdUZxQXNSQTQwZm9JQTBZT3VUM3kxSHdfRk9iektKNEpEZWpPUGkxSzlibFdXdGl2QXA2SE9jYUV4a3pEeHBvbnhELXJBNUdieVlQTkRzZzNZYmpvVDFUNFJzSU9oRTUyTUY1dGo2bjRRMW1nanBUWjg3eGlaQTBXMEJnMVlHTkZIWVBrQlhtZEtJSERsRW1aNGtIeW1NMG56elhhRUVKdzlDTkxwUDhITmc?oc=5","date":"2024-03-13","type":"trial","source":"Eyes On Eyecare","summary":"MediPrint Ophthalmics completes phase 2 study on drug-eluting contact lens - Eyes On Eyecare","headline":"MediPrint Ophthalmics completes phase 2 study on drug-eluting contact lens","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPLUxvN1JTWTgtSzhmS01lVFhCRWRfd2RMSzRKaTl1NVltaWF4Zlh2U2E1d3BxWkQtb0M4X3lWRnZDZWx4UE91V3liemRKRFB0ZmNEbEhMUHpCTlNuLXNMZl8waXEwU1k5Q2xCeTZ3Y3kxOXZkZ0pGUHFVUGdKZnZuYzlXOG5FcmV5VXQ0d215QTRQakZOQmVmZUt3MVc1NW9sTGZFSzEyMGJld2M?oc=5","date":"2024-02-13","type":"pipeline","source":"The AI Journal","summary":"Former CooperVision Leader Tom Bender Joins MediPrint Ophthalmics as Strategic Advisor - The AI Journal","headline":"Former CooperVision Leader Tom Bender Joins MediPrint Ophthalmics as Strategic Advisor","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}